← Leaderboards
Conrad Russell Young Cruz
George Washington University
$3,056,247
Attributed
$8,363,822
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,363,822 · 6
By mechanism
U01$3,221,135 · 1
R33$3,037,329 · 2
R01$1,204,762 · 1
R21$900,596 · 2
Top collaborators
- R. Brad Jones10 shared
- Rohan Fernandes8 shared
- Catherine Mary Bollard5 shared
- Richard J Jones5 shared
- Barbara Savoldo5 shared
Most similar at George Washington University
Same institution · by research overlap
- Rohan Fernandes$4,639,547
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneResponseIn VivoDesignCellsAutologousTissuesNatural Killer CellsMouse ModelPharmaceutical PreparationsT-LymphocyteEngineeringIn VitroSamplingMediatingSiteFrequenciesInterestAntibodiesHiv SeropositivityAdoptive TransferCytotoxic T-LymphocytesHumanized MouseClinical Trials
Grant awards (18)
Photothermal Nanoparticles Immune Engineer Tumor-specific T cells for Adoptive Cell Therapy$369,042
R01 · FY2025 · CA
Photothermal Nanoparticles Immune Engineer Tumor-specific T cells for Adoptive Cell Therapy$236,915
R01 · FY2025 · CA
Photothermal Nanoparticles Immune Engineer Tumor-specific T cells for Adoptive Cell Therapy$598,805
R01 · FY2024 · CA
Enhancing cell therapy for brain tumors$636,818
U01 · FY2022 · CA
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir$485,681
R33 · FY2022 · AI
Enhancing cell therapy for brain tumors$636,455
U01 · FY2021 · CA
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir$485,681
R33 · FY2021 · AI
Enhancing cell therapy for brain tumors$636,807
U01 · FY2020 · CA
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir$516,359
R33 · FY2020 · AI
Engineered CTL with Inducible Ab Secretion; a Tripartite attack on HIV Reservoirs$508,277
R33 · FY2020 · AI
Enhancing cell therapy for brain tumors$636,799
U01 · FY2019 · CA
Engineered CTL with Inducible Ab Secretion; a Tripartite attack on HIV Reservoirs$510,760
R33 · FY2019 · AI
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir$200,479
R21 · FY2019 · AI
Enhancing cell therapy for brain tumors$674,256
U01 · FY2018 · CA
Engineered CTL with Inducible Ab Secretion; a Tripartite attack on HIV Reservoirs$530,571
R33 · FY2018 · AI
Biomaterials-Enhanced NK Cells for Improved Elimination of the HIV Reservoir$234,084
R21 · FY2018 · AI
Engineered CTL with Inducible Ab Secretion; a Tripartite attack on HIV Reservoirs$203,533
R21 · FY2017 · AI
Engineered CTL with Inducible Ab Secretion; a Tripartite attack on HIV Reservoirs$262,500
R21 · FY2016 · AI